This inventor holds 1 USPTO granted patent. Top assignees: Pharmatec Gmbh, University of Florida Research Foundation Inc.. Active years: 1988.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 1988
Title: Warren C Stern: Innovator in Anxiolytic Methods
Introduction
Warren C Stern is a notable inventor based in Gainesville, FL (US). He has made significant contributions to the field of pharmacology, particularly in methods for alleviating anxiety in mammals. His innovative approach has led to the development of a unique patent that addresses a common issue faced by many.
Latest Patents
Warren C Stern holds a patent for a method titled "Method for eliciting anxiolysis." This invention provides a method for relieving anxiety in a mammal using a specific compound. The formula involves a compound where R is either Benzyl or cyclohexyl, or a non-toxic pharmaceutically acceptable salt thereof. A preferred compound for use in this method is 1-methyl-3-{N-[(3'-benzyloxycarbonyl)propyl]}carbamoyl-1,4-dihydropyridine. This patent showcases his innovative approach to addressing anxiety through pharmacological means.
Career Highlights
Throughout his career, Warren C Stern has worked with reputable organizations, including the University of Florida Research Foundation Inc. and Pharmatec GmbH. His experience in these institutions has allowed him to collaborate with other experts in the field and contribute to advancements in medical research.
Collaborations
Warren C Stern has collaborated with James W Simpkins, a fellow researcher. Their partnership has likely fostered innovative ideas and developments in the realm of anxiety treatment.
Conclusion
Warren C Stern's contributions to the field of pharmacology, particularly through his patent for a method of eliciting anxiolysis, highlight his role as an innovator. His work continues to impact the way anxiety is treated in mammals, showcasing the importance of research and innovation in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile